Please assess the completion status of the following clinical trial:

Trial Title: Long Term Follow up of Subjects Exposed to Genetically Engineered T Cell Receptors

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subjects must have received T cell receptor therapy in an Adaptimmune clinical study~* Subjects who have provided informed consent prior to their study participation~Exclusion Criteria:~* Not applicable

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Genetically engineered T Cell Receptor- treated (Type: None): Long term follow-up of subjects with solid or hematological malignancies who have received lentivirus-mediated genetically engineered T Cell Receptors in a previous trial

Based on this trial design, predict the completion outcome and termination type (if applicable).